News
Read more about what we are up to.
PanGenomic Health Subsidiary, MUJN Diagnostics, Announces the Engagement of Hemex Health to Assist in the Development of Brain Health Diagnostics System
Vancouver, British Columbia, Canada, March 30, 2023 – PanGenomic Health Inc. (“PanGenomic Health” or the “Company”) (CSE: NARA), is pleased to announce its subsidiary, MUJN Diagnostics Inc. (“MUJN Diagnostics”), has signed a master services agreement with Hemex Health...
PanGenomic Health Announces the Filing of a Business Acquisition Report for Mindleap Health and Provides Update on UK Listing
VANCOUVER, BC, March 28, 2023 /CNW/ - PanGenomic Health Inc. ("PanGenomic Health" or the "Company") (CSE: NARA), is pleased to announce the filing of its business acquisition report (the "BAR") relating to its acquisition of all outstanding shares of Mindleap Health...
Circle Innovation to Support PanGenomic Health Subsidiary, MUJN Diagnostics, with the Development of its Decision Support System
Vancouver, British Columbia, Canada, March 22, 2023 – PanGenomic Health Inc. (“PanGenomic Health” or the “Company”) (CSE: NARA), is pleased to announce its subsidiary, MUJN Diagnostics Inc. (“MUJN Diagnostics”), is collaborating with Circle Innovation, a non-profit...
PanGenomic Health Announces Availability of Women’s Hormonal Health DNA Report
VANCOUVER, BC, March 8, 2023 /CNW/ - PanGenomic Health Inc. ("PanGenomic Health" or the "Company") (CSE: NARA), is pleased to announce that its new Women's DNA Report is now available and that it has expanded into new geographic markets for its NARA wellness...
PanGenomic Health Provides Corporate Update
VANCOUVER, BC, March 2, 2023 /CNW/ - PanGenomic Health Inc. ("PanGenomic Health" or the "Company") (CSE: NARA), is pleased to provide a corporate update on its strategic initiatives. Acquisition of Mindleap Health Inc. In December 2022, the Company...
PanGenomic Health’s NARA Debuts New Website, Visual Identity & Natural Wellness E-Commerce Store
VANCOUVER, BC, Feb. 9, 2023 /CNW/ - PanGenomic Health Inc. ("PanGenomic Health" or the "Company") (CSE: NARA), is pleased to announce that, further to the announcement made on January 9, 2023, the Company has launched its new visual identity, website and e-commerce...
PanGenomic Health Subsidiary Signs Rental Agreement with Psy Integrated Health, Makes Progress Towards Development of Joint Testing Facility
VANCOUVER, BC, Feb. 2, 2023 /CNW/ - PanGenomic Health Inc. ("PanGenomic Health" or the "Company") (CSE: NARA), is pleased to announce that, further to the announcement made on January 26, 2023, its subsidiary, MUJN Diagnostics Inc. (formerly named PlantGx...
PanGenomic Health Announces Intention to Dual List on the UK Aquis Stock Exchange Growth Market
VANCOUVER, BC, Jan. 31, 2023 /CNW/ - PanGenomic Health Inc. ("PanGenomic Health" or the "Company") (CSE: NARA), is pleased to announce its intention to apply for admission to trading on the Aquis Stock Exchange Growth Market ("AQSE") in the UK. Novum Securities Ltd....
Fobi Announces The Commercial Launch Of PulseIR With First Client, Digital Health Platform PanGenomic Health Inc.
VANCOUVER, BC, Jan. 30, 2023 (GLOBE NEWSWIRE) — Fobi AI Inc. (FOBI:TSXV) (FOBIF:OTCQB) (the “Company” or “Fobi”), an industry leader in harnessing AI and data intelligence to enable digital transformation, is pleased to announce the commercial launch of its...
PanGenomic Health Subsidiary Signs Non-Binding MoU with Psy Integrated Health for Diagnostic Testing Joint Venture
Vancouver, British Columbia, Canada, January 26, 2023 – PanGenomic Health Inc. ("PanGenomic Health" or the "Company") (CSE: NARA), is pleased to announce its subsidiary, MUJN Diagnostics Inc. (formerly named PlantGx Diagnostics Corp.)(“MUJN Diagnostics”), has signed...
PanGenomic Health’s Nara Plant Library is Now Available. Nara App also Supports New FTC Regulatory Guideline for Science-Backed Information about Natural Remedy Alternatives to Pharmaceutical Drugs
VANCOUVER, BC, Jan. 23, 2023 /CNW/ - PanGenomic Health Inc. ("PanGenomic Health" or the "Company") (CSE: NARA), is pleased to announce that its Nara Plant Library is available now on the Nara app as a resource to provide science-backed information about natural remedy...
PanGenomic Health Announces Soft Launch of NARA Personalized DNA Reports and Closing of its Non-Brokered Private Placement Offering
NOT FOR DISTRIBUTION TO U.S. NEWS SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, BC, Jan. 20, 2023 /CNW/ - PanGenomic Health Inc. ("PanGenomic Health" or the "Company") (CSE: NARA), is pleased to announce the soft launch of the "NARA DNA Reports"...
PanGenomic Health’s Mindleap App to Expand
Vancouver, British Columbia, Canada, January 16, 2023 – PanGenomic Health Inc. ("PanGenomic Health" or the "Company") (CSE: NARA) (FSE: LL30) is pleased to announce that its newly-acquired subsidiary, Mindleap Health Inc. ("Mindleap") will be extending its...
PanGenomic Health Subsidiary Signs Partnership with LumiQuick Diagnostics
VANCOUVER, BC, Jan. 12, 2023 /CNW/ - PanGenomic Health Inc. ("PanGenomic Health" or the "Company") (CSE: NARA) is pleased to announce that its subsidiary, PlantGx Diagnostics Corp. ("PlantGx"), has signed a development partnership agreement with LumiQuick Diagnostics,...
PanGenomic Health to Launch E-Commerce Platform for Personalized Natural Health
VANCOUVER, BC, Jan. 9, 2023 /CNW/ - PanGenomic Health Inc. ("PanGenomic Health" or the "Company") (CSE: NARA) is pleased to announce that it plans to launch its e-commerce platform for personalized natural health solutions this month. Built as an extension to its...
PanGenomic Health Retains Capital Markets Advisory Firm
Vancouver, British Columbia, January 3, 2023 – PanGenomic Health Inc. ("PanGenomic" or the "Company") (CSE: NARA) is pleased to announce that Bello Capital Partners ("Bello") has been retained to provide capital markets advisory and digital marketing services...
PanGenomic Health Announces Non-Brokered Private Placement Offering and Closing of First Tranche under Offering
Not for distribution to U.S. news services or for dissemination in the United States Vancouver, British Columbia, December 23, 2022 – PanGenomic Health Inc. ("PanGenomic" or the "Company") (CSE: NARA), is pleased to announce that it has initiated a non-brokered...
Year End Letter to Our Shareholders
DEAR SHAREHOLDERS, As we close out our first year as a publicly-traded company, your team at PanGenomic Health is busy laying the groundwork for success in the burgeoning health technology industry. At the core of our evidence-based health...
PanGenomic Health Enters into Definitive Agreement for Acquisition of Mindleap Health
Not for distribution to U.S. news services or for dissemination in the United States Vancouver, British Columbia, November 21, 2022 – PanGenomic Health Inc. ("PanGenomic"or the"Company") (CSE: NARA), is pleased to announce that, further to its news release dated...
PanGenomic Health Appoints Maryam Marissen as CEO
September 6, 2022 – Vancouver, British Columbia. PanGenomic Health Inc. ("PanGenomic Health" or the "Company") (CSE:NARA) is pleased to announce that Maryam Marissen has been appointed President & CEO, effective immediately. Vincent...
PanGenomic Health Inc. Signs a Non-binding Letter of Intent for the Acquisition of Mindleap Health Inc.
Vancouver, British Columbia, Sept. 1, 2022 – PanGenomic Health Inc. ("PanGenomic" or the "Company") (CSE:NARA), is pleased to announce that the Company has signed an arm’s length non-binding Letter of Intent (“LOI”) with Mydecine Innovations Group Inc....
Natural Remedy App Launched to Support Mental Health
VANCOUVER, BC, August XX, 2022 – PanGenomic Health Inc. (CSE:NARA) (the "Company" or "PanGenomic Health") is pleased to announce that its Nara app is now available for download in North America on the Apple App Store and the Google...
PanGenomic Health engages Investor Relations Services Provider, Meus Management, and Market Maker Services Provider, Generation IACP
July 20, 2022 – Vancouver, British Columbia. PanGenomic Health Inc. (“PanGenomic”) (CSE: NARA) is pleased to announce that it has engaged Meus Management Inc. (“Meus”) to provide capital markets advisory, investor relations and corporate strategy services. ...
PanGenomic Health Inc. Acquires Behavioural Nudge Technology
VANCOUVER, BC, March 21, 2022 – PanGenomic Health Inc.(the “Company” or “PanGenomic Health”) is pleased to announce that it has acquired certain intellectual property assets (the “LivNao IP”) from LivNao Technologies Corp (“LivNao”). The patent-pending...
PanGenomic Health Launches Mental Health App
VANCOUVER, BC, March 16, 2022 – PanGenomic Health Inc. (the “Company” or “PanGenomic Health”) is pleased to announce that it has released its beta version of the Nara app that provides consumers with personalized information about natural remedy solutions to...
PanGenomic Health Corp. Completes Sale to Zetta Capital Corp.
VANCOUVER, BC, November 9, 2021 – PanGenomic Health Corp. (the “Company” or “PanGenomic Health”) is pleased to announce that its shareholders have approved the sale of all of the issued and outstanding shares of the Company to Zetta Capital Corp. (“Zetta Capital”) of...